Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Gina Gualano and Fabrizio Palmieri.
Gina Gualano
Connection Strength
2.461
Fabrizio Palmieri
  1. Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report. Int J Infect Dis. 2020 Aug; 97:174-176.
    View in: PubMed
    Score: 0.881
  2. Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital. Antibiotics (Basel). 2021 Mar 08; 10(3).
    View in: PubMed
    Score: 0.233
  3. Dermatological manifestations during COVID-19 and histological picture: Description of two clinical cases. J Dermatol. 2021 May; 48(5):651-656.
    View in: PubMed
    Score: 0.233
  4. Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy. Infection. 2021 Oct; 49(5):1061-1064.
    View in: PubMed
    Score: 0.231
  5. Tuberculin skin test - Outdated or still useful for Latent TB infection screening? Int J Infect Dis. 2019 Mar; 80S:S20-S22.
    View in: PubMed
    Score: 0.202
  6. Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection. J Transl Med. 2021 06 26; 19(1):272.
    View in: PubMed
    Score: 0.060
  7. Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2. Int J Infect Dis. 2021 Dec; 113 Suppl 1:S82-S87.
    View in: PubMed
    Score: 0.058
  8. Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital. Int J Infect Dis. 2021 Apr; 105:532-539.
    View in: PubMed
    Score: 0.058
  9. In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy. J Infect. 2021 04; 82(4):58-66.
    View in: PubMed
    Score: 0.058
  10. A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients. Clin Microbiol Infect. 2021 Feb; 27(2):286.e7-286.e13.
    View in: PubMed
    Score: 0.057
  11. Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January-April 2020. Emerg Infect Dis. 2020 11; 26(11):2709-2712.
    View in: PubMed
    Score: 0.056
  12. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J. 2020 07; 56(1).
    View in: PubMed
    Score: 0.056
  13. Burden and Characteristics of the Comorbidity Tuberculosis-Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study. Open Forum Infect Dis. 2019 Jan; 6(1):ofy337.
    View in: PubMed
    Score: 0.050
  14. ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 update. Eur Respir J. 2018 05; 51(5).
    View in: PubMed
    Score: 0.048
  15. Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy. PLoS One. 2017; 12(12):e0189425.
    View in: PubMed
    Score: 0.047
  16. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. Eur Respir J. 2017 05; 49(5).
    View in: PubMed
    Score: 0.045
  17. Safety and tolerability of clarithromycin in the treatment of multidrug-resistant tuberculosis. Eur Respir J. 2017 03; 49(3).
    View in: PubMed
    Score: 0.044
  18. Modulation of CD4 and CD8 response to QuantiFERON-TB Plus in patients with active tuberculosis and latent tuberculosis infection followed over time during treatment. Int J Mycobacteriol. 2016 Dec; 5 Suppl 1:S141-S142.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.